TrialJournal of neuro-oncology2016

A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.

Ralph Salloum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.